Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Accumulated Expenses (2023 - 2025)

Historic Accumulated Expenses for Jin Medical International (ZJYL) over the last 3 years, with Q3 2025 value amounting to $673472.0.

  • Jin Medical International's Accumulated Expenses rose 5625.69% to $673472.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $673472.0, marking a year-over-year increase of 5625.69%. This contributed to the annual value of $673472.0 for FY2025, which is 5625.69% up from last year.
  • Per Jin Medical International's latest filing, its Accumulated Expenses stood at $673472.0 for Q3 2025, which was up 5625.69% from $431003.0 recorded in Q3 2024.
  • Over the past 5 years, Jin Medical International's Accumulated Expenses peaked at $673472.0 during Q3 2025, and registered a low of $318500.0 during Q3 2023.
  • Its 3-year average for Accumulated Expenses is $474325.0, with a median of $431003.0 in 2024.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 3532.28% in 2024, then surged by 5625.69% in 2025.
  • Jin Medical International's Accumulated Expenses (Quarter) stood at $318500.0 in 2023, then soared by 35.32% to $431003.0 in 2024, then skyrocketed by 56.26% to $673472.0 in 2025.
  • Its last three reported values are $673472.0 in Q3 2025, $431003.0 for Q3 2024, and $318500.0 during Q3 2023.